Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Impact of New SARS-CoV-2 Variants on Vaccine Breakthrough: A Pilot Study on Spreading Infection in the Communities

Mohamad Ammar Ayass, Jin Zhang, Kevin Zhu, Wanying Cao, Natalya Griko, Victor Pashkov, Jun Dai, Trivendra Tripathi, Lina Abi Mosleh
doi: https://doi.org/10.1101/2021.09.21.21263898
Mohamad Ammar Ayass
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mayass{at}ayassbioscience.com
Jin Zhang
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Zhu
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanying Cao
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalya Griko
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Pashkov
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Dai
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trivendra Tripathi
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lina Abi Mosleh
Ayass Bioscience LLC, Frisco, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.09.21.21263898
History 
  • September 26, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Mohamad Ammar Ayass*,
  2. Jin Zhang,
  3. Kevin Zhu,
  4. Wanying Cao,
  5. Natalya Griko,
  6. Victor Pashkov,
  7. Jun Dai,
  8. Trivendra Tripathi and
  9. Lina Abi Mosleh
  1. Ayass Bioscience LLC, Frisco, Texas
  1. ↵*Corresponding author; email: mayass{at}ayassbioscience.com
Back to top
PreviousNext
Posted September 26, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Impact of New SARS-CoV-2 Variants on Vaccine Breakthrough: A Pilot Study on Spreading Infection in the Communities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Impact of New SARS-CoV-2 Variants on Vaccine Breakthrough: A Pilot Study on Spreading Infection in the Communities
Mohamad Ammar Ayass, Jin Zhang, Kevin Zhu, Wanying Cao, Natalya Griko, Victor Pashkov, Jun Dai, Trivendra Tripathi, Lina Abi Mosleh
medRxiv 2021.09.21.21263898; doi: https://doi.org/10.1101/2021.09.21.21263898
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The Impact of New SARS-CoV-2 Variants on Vaccine Breakthrough: A Pilot Study on Spreading Infection in the Communities
Mohamad Ammar Ayass, Jin Zhang, Kevin Zhu, Wanying Cao, Natalya Griko, Victor Pashkov, Jun Dai, Trivendra Tripathi, Lina Abi Mosleh
medRxiv 2021.09.21.21263898; doi: https://doi.org/10.1101/2021.09.21.21263898

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5130)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)